- Home
- PFO vs LFCR Comparison
PFO vs LFCR Comparison
Compare PFO & LFCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PFO
- LFCR
- Stock Information
- Founded
- PFO 1991
- LFCR 1986
- Country
- PFO United States
- LFCR United States
- Employees
- PFO N/A
- LFCR N/A
- Industry
- PFO Finance Companies
- LFCR Biotechnology: Pharmaceutical Preparations
- Sector
- PFO Finance
- LFCR Health Care
- Exchange
- PFO Nasdaq
- LFCR Nasdaq
- Market Cap
- PFO 116.6M
- LFCR 308.8M
- IPO Year
- PFO N/A
- LFCR N/A
- Fundamental
- Price
- PFO $9.26
- LFCR $8.30
- Analyst Decision
- PFO
- LFCR Buy
- Analyst Count
- PFO 0
- LFCR 4
- Target Price
- PFO N/A
- LFCR $8.00
- AVG Volume (30 Days)
- PFO 31.8K
- LFCR 224.7K
- Earning Date
- PFO 01-01-0001
- LFCR 08-25-2025
- Dividend Yield
- PFO 6.51%
- LFCR N/A
- EPS Growth
- PFO N/A
- LFCR N/A
- EPS
- PFO N/A
- LFCR N/A
- Revenue
- PFO N/A
- LFCR $130,309,000.00
- Revenue This Year
- PFO N/A
- LFCR $1.64
- Revenue Next Year
- PFO N/A
- LFCR $2.91
- P/E Ratio
- PFO N/A
- LFCR N/A
- Revenue Growth
- PFO N/A
- LFCR 7.23
- 52 Week Low
- PFO $6.90
- LFCR $3.68
- 52 Week High
- PFO $8.51
- LFCR $8.85
- Technical
- Relative Strength Index (RSI)
- PFO 59.15
- LFCR 62.25
- Support Level
- PFO $9.15
- LFCR $8.10
- Resistance Level
- PFO $9.37
- LFCR $8.32
- Average True Range (ATR)
- PFO 0.08
- LFCR 0.39
- MACD
- PFO -0.00
- LFCR 0.04
- Stochastic Oscillator
- PFO 65.95
- LFCR 71.05
About PFO Flaherty & Crumrine Preferred and Income Opportunity Fund Incorporated
Flaherty & Crumrine Prfd Income Oppo is the United States-based diversified, closed-end management investment company. Its primary investment objective is to provide its common shareholders with high current income consistent with the preservation of capital. The fund invests in a diversified portfolio of preferred securities which includes traditional preferred stocks eligible for the inter-corporate dividends received a deduction and fully taxable preferred securities.
About LFCR Lifecore Biomedical Inc.
Lifecore Biomedical Inc is a fully integrated contract development and manufacturing organization (CDMO) that offers differentiated capabilities in the development, filling, and finishing of complex sterile injectable pharmaceutical products in syringes and vials. It manufactures injectable-grade Hyaluronic Acid. Lifecore recognizes revenue in two different product categories, CDMO and fermentation.